Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1528-3658

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets ; volume:24 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-8 ; date:12.2018
Molecular medicine ; 24, Heft 1 (15.3.2018), 1-8, 12.2018

Creator: Izzo, Antonella

Contributor: Mollo, Nunzia
Nitti, Maria
Paladino, Simona
Calì, Gaetano
Genesio, Rita
Bonfiglio, Ferdinando
Cicatiello, Rita
Barbato, Maria
Sarnataro, Viviana
Conti, Anna
Nitsch, Lucio
SpringerLink (Online service)

DOI: 10.1186/s10020-018-0004-y

URN: urn:nbn:de:1111-20180528854

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Izzo, Antonella
Mollo, Nunzia
Nitti, Maria
Paladino, Simona
Calì, Gaetano
Genesio, Rita
Bonfiglio, Ferdinando
Cicatiello, Rita
Barbato, Maria
Sarnataro, Viviana
Conti, Anna
Nitsch, Lucio
SpringerLink (Online service)

Other Objects (12)

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells

FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis

Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets : Micro-RNA 92a as a therapeutic target for cardiac microvascular dysfunction in diabetes

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Related objects

Reset password